Bharat Book Bureau Provides the Trending Market Research Report on “Pediatric Vaccines Global Market Report 2020-30”under Medical Devices Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Pediatric Vaccines Market Global Report 2020: Covid 19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global pediatric vaccines market as it emerges from the Covid 19 shut down.

Request a free sample copy of Pediatric Vaccines Global Market Report@https://www.bharatbook.com/marketreports/sample/reports/2052456

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the pediatric vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Pediatric Vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pediatric vaccines market, and compares it with other markets.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
• The pediatric vaccines market section of the report gives context. It compares the pediatric vaccines market with other segments of the pediatric vaccines market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, pediatric vaccines indicators comparison.

Scope
Markets Covered: 1) By Vaccine Type: Monovalent; Multivalent; 2) By Technology: Live Attenuated; Inactivated; Toxoid; Conjugate; Other Technologies

Companies Mentioned: GlaxoSmithKline plc; Pfizer Inc.; Sanofi S.A.; Merck & Co., Inc.; Indian Immunologicals Limited

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Major players in the pediatric vaccines market are GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Indian Immunologicals Limited, AstraZeneca plc, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd. and Panacea Biotec Ltd.

The global pediatric vaccines is expected to decline from $30.4 billion in 2019 to $28.9 billion in 2020 at a compound annual growth rate (CAGR) of -5%. The decline is mainly due to the focus on Covid-19 outbreak and its treatment across the globe and non-availability of vaccines or delay of immunizations in pediatrics.

The market will stabilize or grow from next year owing to the easing of supply chain restrictions. Also, successful launch of the covid19 vaccine or immunization of existing BCG vaccine in countries where it is not administered at present, which will boost the pediatric vaccines market significantly in the mid to long term. The market is expected to recover and reach $40.7 billion in 2023 at a CAGR of 7.8%.

The pediatric vaccines market consists of sales of pediatric vaccines and its related services used to provide immunity to infants and children for specific diseases. Pediatric vaccine is a preparation of killed microorganisms, living attenuated organisms, or living fully virulent organisms that are administered to stimulate the production of antibodies and provide immunity against one or several diseases among children.

Pediatric vaccines are used in childhood immunization schedules to enhance a child’s immunity or prevent diseases such as diphtheria, tetanus, pertussis, influenza, Hepatitis B, polio and many other infectious and non-infectious diseases.

The pediatric vaccines market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019. Asia Pacific was the fastest region during the period 2019-2025.

The pediatric vaccines market covered in this report is segmented by vaccine type into monovalent, multivalent and by technology into live attenuated, inactivated, toxoid, conjugate, and other technologies.

Vaccine refusal by parents for their children is a prevailing tradition in many countries. Among the reasons for withholding children for vaccination are lack of knowledge, religious and philosophical objections, exaggerated concerns regarding vaccine safety and others. According to a report published by CNBC, the US national refusal rate of parents for a child’s immunization was 3.3% in 2018.

Governments are imposing laws and organizing awareness programs to overcome parent’s and family’s resistance to the child’s vaccine, but are unable to impose any strict rules against parents’ refusal for children’s immunization, which is hindering the pediatric vaccines market’s growth.

The demand for novel vaccines is steadily growing to deliver improved immunization against challenging infectious diseases (e.g. tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations.

To meet the increasing demand for novel vaccines, there is a continuous quest in pediatric vaccine manufacturers and developers for innovation of vaccine design and manufacturing technologies.

For instance, in January 2020, Hilleman laboratories, a global research, and development organization, has announced their plans to develop a novel vaccine against Group B Streptococcus, a major cause for neonatal infections in women, into the area of maternal and child health.

Rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below will contribute to the growth of the pediatric vaccines market. The risk of severe disease outcomes and complications of infectious diseases are increasing in children and adolescents with chronic conditions.

As stated by centers for disease control and prevention, the prevalence of obesity was 18.5% in the US and about 13.7 million children and adolescents were affected by obesity in 2015. The increased prevalence of chronic diseases among children rises the demand for immunization from chronic diseases, hence, driving the pediatric vaccines market’s growth.

Browse our full report with Table of Content: https://www.bharatbook.com/marketreports/pediatric-vaccines-global-market-report-2020-30/2052456

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 12,00,000 reports and insights that includes latest Market Study, Market Trends and Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com